Sage Journals: Discover world-class research

Retricted access

Case report

First published 2023-9

Extemporaneous compounding of dabrafenib and trametinib for cancer patients with feeding tubes

Trinh Bui, Van Vu, Darren Luon

Journal of Oncology Pharmacy Practice

Retricted access

Case report

First published 2017-11

Choroidal Neovascularization in Multifocal Choroiditis after Dabrafenib and Trametinib

Giorgia C. Albertini, Eleonora Corbelli, Maurizio Battaglia Parodi [...]

European Journal of Ophthalmology

Open access

Research article

First published 2025

Halofuginone induces ERK phosphorylation and synergizes with trametinib in gastric cancer cells

Yuemin Sun, Peng Wang, Xiaofeng Bai [...]

International Journal of Immunopathology and Pharmacology

Open access

Research article

First published 2024

Enhancing efficacy of the MEK inhibitor trametinib with paclitaxel in KRAS -mutated colorectal cancer

Susmita Ghosh, Fan Fan, Reid Powell [...]

Therapeutic Advances in Medical Oncology

Open access

Research article

First published 2023-12

Outcomes in patients with BRAF V600 –mutated melanoma and brain metastases at baseline treated with dabrafenib plus trametinib

Massimo Aglietta, Vanna Chiarion-Sileni, Paolo Fava [...]

Tumori Journal

Retricted access

Research article

First published 2016-9

Combined Therapy with Dabrafenib and Trametinib in BRAF -Mutated Metastatic Melanoma in a Real-Life Setting: The INT Milan Experience

Stefano Cavalieri, Lorenza Di Guardo, Carolina Cimminiello [...]

Tumori Journal

Retricted access

Case report

First published 2015-8

Facing the challenges of new melanoma-targeted therapies: Treatment of severe fevers associated with dabrafenib/trametinib combination therapy

Julian N Lindsay, Michael Barras

Journal of Oncology Pharmacy Practice

Retricted access

Case report

First published 2023-12

Demyelinating polyradiculoneuropathy during dabrafenib and trametinib treatment for metastatic melanoma: A case report

Marta Venturelli, Stefano Greco, Cinzia Baldessari [...]

Tumori Journal

Open access

Research article

First published 2022

Delphi panel for consensus on the optimal management of dabrafenib plus trametinib-related pyrexia in patients with melanoma

Ricky Frazer, Avinash Gupta, Christopher Herbert [...]

Therapeutic Advances in Medical Oncology

Open access

Research article

First published 2022-12-09

Predictive biomarkers for response to trametinib in non-small cell lung cancer

Palak R. Parekh, Gregory M. Botting, Denise B. Thurber [...]

Tumor Biology

Search results